Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4CCC

STRUCTURE OF MOUSE GALACTOCEREBROSIDASE WITH 4NBDG: ENZYME-SUBSTRATE COMPLEX

Summary for 4CCC
Entry DOI10.2210/pdb4ccc/pdb
Related4CCD 4CCE
DescriptorGALACTOCEREBROSIDASE, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 4-nitrophenyl beta-D-galactopyranoside, ... (6 entities in total)
Functional Keywordshydrolase, krabbe disease, glycosyl hydrolase, 4-nitrophenyl-beta-d-galactopyranoside, lysosomal storage disease, enzyme- substrate complex
Biological sourceMUS MUSCULUS (HOUSE MOUSE)
Cellular locationLysosome (By similarity): P54818
Total number of polymer chains1
Total formula weight76432.49
Authors
Hill, C.H.,Graham, S.C.,Read, R.J.,Deane, J.E. (deposition date: 2013-10-21, release date: 2013-12-11, Last modification date: 2024-10-23)
Primary citationHill, C.H.,Graham, S.C.,Read, R.J.,Deane, J.E.
Structural Snapshots Illustrate the Catalytic Cycle of Beta-Galactocerebrosidase, the Defective Enzyme in Krabbe Disease
Proc.Natl.Acad.Sci.USA, 110:20479-, 2013
Cited by
PubMed Abstract: Glycosphingolipids are ubiquitous components of mammalian cell membranes, and defects in their catabolism by lysosomal enzymes cause a diverse array of diseases. Deficiencies in the enzyme β-galactocerebrosidase (GALC) cause Krabbe disease, a devastating genetic disorder characterized by widespread demyelination and rapid, fatal neurodegeneration. Here, we present a series of high-resolution crystal structures that illustrate key steps in the catalytic cycle of GALC. We have captured a snapshot of the short-lived enzyme-substrate complex illustrating how wild-type GALC binds a bona fide substrate. We have extensively characterized the enzyme kinetics of GALC with this substrate and shown that the enzyme is active in crystallo by determining the structure of the enzyme-product complex following extended soaking of the crystals with this same substrate. We have also determined the structure of a covalent intermediate that, together with the enzyme-substrate and enzyme-product complexes, reveals conformational changes accompanying the catalytic steps and provides key mechanistic insights, laying the foundation for future design of pharmacological chaperones.
PubMed: 24297913
DOI: 10.1073/PNAS.1311990110
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.09 Å)
Structure validation

237735

건을2025-06-18부터공개중

PDB statisticsPDBj update infoContact PDBjnumon